Dillon H. Miles

485 total citations
18 papers, 248 citations indexed

About

Dillon H. Miles is a scholar working on Organic Chemistry, Physiology and Immunology. According to data from OpenAlex, Dillon H. Miles has authored 18 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 7 papers in Physiology and 4 papers in Immunology. Recurrent topics in Dillon H. Miles's work include Adenosine and Purinergic Signaling (7 papers), Click Chemistry and Applications (4 papers) and Phagocytosis and Immune Regulation (4 papers). Dillon H. Miles is often cited by papers focused on Adenosine and Purinergic Signaling (7 papers), Click Chemistry and Applications (4 papers) and Phagocytosis and Immune Regulation (4 papers). Dillon H. Miles collaborates with scholars based in United States and Germany. Dillon H. Miles's co-authors include F. Dean Toste, Manuel Orlandi, Matthew S. Sigman, Mathias Turberg, Koji Kubota, Jay P. Powers, Manmohan R. Leleti, Ehesan U. Sharif, Brandon R. Rosen and Stephen W. Young and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Cancer Research.

In The Last Decade

Dillon H. Miles

16 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dillon H. Miles United States 8 188 77 46 35 15 18 248
Tanner C. Jankins United States 9 323 1.7× 125 1.6× 12 0.3× 44 1.3× 4 0.3× 18 372
Frank Volz Germany 6 293 1.6× 68 0.9× 19 0.4× 39 1.1× 7 0.5× 7 322
Pilar Calleja Spain 8 282 1.5× 68 0.9× 2 0.0× 33 0.9× 7 0.5× 13 336
Ivan Hemeon Canada 7 117 0.6× 13 0.2× 5 0.1× 105 3.0× 3 0.2× 14 228
Olivier Bedel France 7 77 0.4× 10 0.1× 13 0.3× 45 1.3× 2 0.1× 13 121
Natalie H. Jones United States 7 250 1.3× 22 0.3× 8 0.2× 35 1.0× 9 315
Zhefan Zhang China 9 236 1.3× 201 2.6× 2 0.0× 64 1.8× 7 0.5× 14 331
Mohsine Driowya France 11 323 1.7× 9 0.1× 8 0.2× 113 3.2× 1 0.1× 21 370
Franck Silva United Kingdom 6 386 2.1× 55 0.7× 54 1.5× 7 0.5× 8 426
Lutz Richter Germany 11 269 1.4× 33 0.4× 3 0.1× 234 6.7× 3 0.2× 18 367

Countries citing papers authored by Dillon H. Miles

Since Specialization
Citations

This map shows the geographic impact of Dillon H. Miles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dillon H. Miles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dillon H. Miles more than expected).

Fields of papers citing papers by Dillon H. Miles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dillon H. Miles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dillon H. Miles. The network helps show where Dillon H. Miles may publish in the future.

Co-authorship network of co-authors of Dillon H. Miles

This figure shows the co-authorship network connecting the top 25 collaborators of Dillon H. Miles. A scholar is included among the top collaborators of Dillon H. Miles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dillon H. Miles. Dillon H. Miles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lamani, Manjunath, Ehesan U. Sharif, Joice Thomas, et al.. (2025). Discovery and Characterization of Potent, Selective, and Orally Bioavailable 7-Azaindazole AXL Receptor Tyrosine Kinase Inhibitors. Journal of Medicinal Chemistry. 68(11). 10677–10703. 1 indexed citations
2.
Sharif, Ehesan U., Dillon H. Miles, Brandon R. Rosen, et al.. (2024). Abstract PR001: Discovery of Etrumadenant, a first-in-class dual A2a and A2b adenosine receptor antagonist for cancer immunotherapy. Molecular Cancer Therapeutics. 23(12_Supplement). PR001–PR001.
3.
Leslie, Jhansi L., et al.. (2023). Abstract 518: AB801 is a highly potent and selective AXL kinase inhibitor that demonstrates significant anti-tumor activity. Cancer Research. 83(7_Supplement). 518–518. 1 indexed citations
4.
Mailyan, Artur K., Guillaume Mata, Dillon H. Miles, et al.. (2022). Development of a Robust and Scalable Synthetic Route for a Potent and Selective Isoindolinone PI3Kγ Inhibitor. Organic Process Research & Development. 26(10). 2915–2925. 6 indexed citations
5.
Sharif, Ehesan U., Jarosław Kalisiak, Kenneth V. Lawson, et al.. (2021). Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors. Journal of Medicinal Chemistry. 64(1). 845–860. 26 indexed citations
6.
Miles, Dillon H., Manmohan R. Leleti, Xiao‐Fan Zhao, et al.. (2020). Discovery and characterization of potent and selective AXL receptor tyrosine kinase inhibitors for cancer therapy. European Journal of Cancer. 138. S38–S39. 1 indexed citations
7.
Sharif, Ehesan U., Dillon H. Miles, Brandon R. Rosen, et al.. (2020). Development of a Scalable and Practical Synthesis of AB928, a Dual A2a/A2b Receptor Antagonist. Organic Process Research & Development. 24(7). 1254–1261. 3 indexed citations
8.
Chen, Yu, Dillon H. Miles, Akshata R. Udyavar, et al.. (2020). Kinetic and Mechanistic Characterization of a Potent and Selective Inhibitor for Human AXL Receptor Tyrosine Kinase. The FASEB Journal. 34(S1). 1–1. 1 indexed citations
9.
Rosen, Brandon R., et al.. (2020). Improved synthesis of sterically encumbered heteroaromatic biaryls from aromatic β-keto esters. Tetrahedron Letters. 61(20). 151855–151855. 4 indexed citations
10.
DiRenzo, Daniel, Joanne B.L. Tan, Dillon H. Miles, et al.. (2019). Abstract A162: AB928, a dual antagonist of the A2aR and A2bR adenosine receptors, relieves adenosine-mediated immune suppression. Cancer Immunology Research. 7(2_Supplement). A162–A162. 7 indexed citations
11.
Seitz, Lisa, Manmohan R. Leleti, Jay P. Powers, et al.. (2018). Final results of the phase I study in healthy volunteers of AB928, a dual antagonist of the A2aR and A2bR adenosine receptors being studied as an activator of anti-tumor immune response. Annals of Oncology. 29. viii665–viii665. 2 indexed citations
12.
Tan, Joanne B.L., Daniel DiRenzo, F Yin, et al.. (2018). Abstract 5556: Combining adenosine receptor inhibition with AB928 and chemotherapy results in greater immune activation and tumor control. Cancer Research. 78(13_Supplement). 5556–5556. 9 indexed citations
13.
Schindler, Ulrike, Lisa Seitz, Joanne B.L. Tan, et al.. (2018). AB928, a dual antagonist of the A 2a R and A 2b R adenosine receptors, leads to greater immune activation and reduced tumor growth when combined with chemotherapy. European Journal of Cancer. 92. S14–S15. 5 indexed citations
14.
Kubota, Koji, Manuel Orlandi, Mathias Turberg, et al.. (2017). Enantioselective Synthesis ofN,S‐Acetals by an Oxidative Pummerer‐Type Transformation using Phase‐Transfer Catalysis. Angewandte Chemie International Edition. 57(2). 589–593. 37 indexed citations
15.
Kubota, Koji, Manuel Orlandi, Mathias Turberg, et al.. (2017). Enantioselective Synthesis ofN,S‐Acetals by an Oxidative Pummerer‐Type Transformation using Phase‐Transfer Catalysis. Angewandte Chemie. 130(2). 598–602. 7 indexed citations
16.
Miles, Dillon H., et al.. (2015). A Nucleophilic Strategy for Enantioselective Intermolecular α-Amination: Access to Enantioenriched α-Arylamino Ketones. Journal of the American Chemical Society. 137(24). 7632–7635. 63 indexed citations
17.
Popp, Brian V., et al.. (2014). Stabilization and functionalization of single‐walled carbon nanotubes with polyvinylpyrrolidone copolymers for applications in aqueous media. Journal of Polymer Science Part A Polymer Chemistry. 53(2). 337–343. 11 indexed citations
18.
Miles, Dillon H., et al.. (2013). Gold( i )-catalyzed enantioselective bromocyclization reactions of allenes. Chemical Science. 4(9). 3427–3431. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tanner C. Jankins Breakdown of academic impact, for papers by Frank Volz Breakdown of academic impact, for papers by Pilar Calleja Breakdown of academic impact, for papers by Ivan Hemeon Breakdown of academic impact, for papers by Olivier Bedel Breakdown of academic impact, for papers by Natalie H. Jones Breakdown of academic impact, for papers by Zhefan Zhang Breakdown of academic impact, for papers by Mohsine Driowya Breakdown of academic impact, for papers by Franck Silva Breakdown of academic impact, for papers by Lutz Richter
Rankless by CCL
2026